VVTM VVT Med Inc.

0.1188USD0.1700 CAD · TSXV+6.25%Mkt Cap: 8.63M USDP/E: —

VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for vein diameters; and ScleroSa…

Institutional holders1 on file

Key Statistics

Company
Market Cap8.63M USD
Enterprise Value9.43M USD
Revenue (TTM)96.00K USD
Gross Profit63.00K USD
Net Income (TTM)-3.98M USD
Revenue/Share0.0010 USD
Last Price0.1188 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees8
CountryCA
SectorHealthcare
IndustryMedical Devices
ISINCA91841T1084
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-4.48
EV/Revenue98.28
P/S128.55
P/B-4.84
EPS (TTM)-0.11 USD
EPS (Forward)—
52W Range
0.097910% of range0.3146
52W High0.3146 USD
52W Low0.0979 USD
Profitability
Gross Margin70.79%
Oper. Margin-3144.79%
EBITDA Margin0.00%
Profit Margin-4467.42%
ROE218.46%
ROA-434.06%
ROIC—
ROCE—
Growth
Revenue Growth135.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.16M USD
CapEx (TTM)4.00K USD
FCF Margin-1088.95%
FCF Yield-12.12%
Net Debt1.16M USD
Net Debt/EBITDA-0.38
Net Debt/FCF—
Balance Sheet
Debt/Equity-0.58
Current Ratio0.16
Quick Ratio0.03
Book Value/Sh-0.04 USD
Cash/Share0.00 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateSep 11, 2020
Splits
Last Split214:1000
Split DateJul 31, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.72.59M
Float61.09M
Insiders15.83%
Institutions0.00%
Short Interest
Short Ratio3.5d
Short % Out.0.00%
Shares Short827
Short (prev mo.)339
Technical
SMA 500.1325 (-10.3%)
SMA 2000.1570 (-24.3%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)4.90K
Avg Vol (10d)7.90K
Technical Indicators
RSI (14)45.3
MACD-0.0104
MACD Signal-0.0101
MACD Hist.-0.0002
BB Upper0.1523 USD
BB Middle0.1236 USD
BB Lower0.0948 USD
BB Width46.48%
ATR (14)0.0068 USD
Vol Ratio (20d)0.07x

About VVT Med (CVE: VVTM)

›

VVT Med (CVE: VVTM) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 8 employees.

The shares were at 0.1700 CAD on 19 November 2026, down 39.3% over 52 weeks. Its 52-week range is 0.1400 CAD to 0.4500 CAD: the price is 62.2% below the high and 21.4% above the low.

Its market capitalisation is 12.34M CAD.

VVT Med reports return on equity of 218.5% and revenue up 135.7% year over year.

Its debt exceeds its cash by 1.16M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. The next earnings report is expected on 1 December 2026.